发明名称 |
ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE |
摘要 |
The present disclosure provides pharmaceutical formulations for sustained release, and methods for delivering a treatment regimen with a combination of sustained release and long half-life formulations. The disclosure provides improved pharmacokinetics for peptide and small molecule drugs. |
申请公布号 |
WO2016081884(A2) |
申请公布日期 |
2016.05.26 |
申请号 |
WO2015US61955 |
申请日期 |
2015.11.20 |
申请人 |
PHASEBIO PHARMACEUTICALS, INC. |
发明人 |
JOWETT, JAMES;BALLANCE, DAVID JAMES |
分类号 |
A61K38/39 |
主分类号 |
A61K38/39 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|